Unbiased Analysis of Today's Healthcare Issues
That is the title of an article published in Pharmaceutical Technology today. I am quoted extensively. For instance, President Biden proposes to cap drug prices at genera rates of inflation. The article highlights some limits this would pose to value-based pricing that could evolve over time: Shafrin also says while Biden’s plan to penalise companies…
A paper from Nayak et al. (2021) in JAMA Internal Medicine describes how public-private partnerships have helped bring new biologic drugs to market. Using data on new biologic drugs approved by the FDA’s Center for Drug Evaluation and Reseach (CDER) and US patent office data, the authors find that: Twenty-nine drugs (42%) showed evidence of…
That is the finding from a white paper from the Schizophrenia and Psychosis Action Alliance titled “Societal Costs of Schizophrenia & Related Disorders“. I am a co-author on the paper. Below is a summary of the findings: …the societal costs of schizophrenia were estimated to be $281.6 billion in 2020…Direct costs for individuals living with…
Last Friday, President Biden released an executive order titled “Promoting Competition in the American Economy” While the order talk about transportation, internet companies, and farming, there were a number of provisions related to health care. I summarize each of these below. Specifically I review OTC hearing aids. Currently, many patients need to visit a doctor…
Cell and gene therapies have the potential to produce dramatic improvements in quality of life and survival for severe and often rare diseases. Currently, however, the cost of these treatments is high and access is sometimes limited. To identify some of these challenges in Europe EURODIS conducted an evaluation of country-specific challenges with respect to…
That is the title of a 2016 NBER chapter by Heidi Williams and the subtitle is “Evidence from Health Care Markets“. Economic theory back to Nordhaus (1969) predicts that intellectual property rights increase the incentive for firms to invest in research and development and likely this would lead to more innovation. Proving these empirically, however,…
Healthcare Economist was named one of the top 30 health policy blogs on the web by Feedspot. In fact we came in at #4! The top 5 are: Bill of Health USC-Brookings Schaeffer Initiative for Health Policy The Health Care Blog (Health Policy) Healthcare Economist Health Populi. You can review the full list here.
A paper by Lurie et al. (2021) provides the answer. They reach four conclusions from their analysis: First, the actual penalty paid per uninsured month is less than half the statutory amount. Second, nonetheless, we find visually clear and statistically significant responses to both extensive margin exposure to the mandate and to marginal increases in…
The answer to this question likely will be shaped in part by a new multilateral working group that will include not only representatives from the U.S. (U.S. Department of Justice Antitrust Division, and Offices of State Attorneys General), but also Canada (Canadian Competition Bureau), Europe (the European Commission Directorate General for Competition) and the United…
To get people vaccinated for COVID-19, a lot of things have to go right. First, you have to have purchased the vaccine. Second, you need a supply chain to be able to deliver the vaccine. Third (or perhaps first) you need people who actually are interested in receiving the vaccine. As you can see from…